Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays.

Harrington, Patrick R; Komatsu, Takashi E; Sun, Hengrui; Naeger, Lisa K

Harrington, Patrick R; Komatsu, Takashi E; Sun, Hengrui; Naeger, Lisa K.

Afiliação

Harrington PR; Division of Antiviral Products, Office of Antimicrobial Products, Silver Spring, Maryland.
Komatsu TE; Division of Antiviral Products, Office of Antimicrobial Products, Silver Spring, Maryland.
Sun H; Division of Biometrics IV, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Naeger LK; Division of Antiviral Products, Office of Antimicrobial Products, Silver Spring, Maryland.

Clin Infect Dis ; 70(2): 327-330, 2020 01 02.

Article em En | MEDLINE | ID: mdl-31075159

Assuntos

Antivirais; Hepatite C Crônica; Antivirais/uso terapêutico; Hepacivirus/genética; Hepatite C Crônica/diagnóstico; Hepatite C Crônica/tratamento farmacológico; Humanos; RNA Viral; Resposta Viral Sustentada

Palavras-chave

HCV RNA; HCV core antigen; direct-acting antivirals; hepatitis C virus; relapse

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article